Exact Mass: 492.2179578
Exact Mass Matches: 492.2179578
Found 241 metabolites which its exact mass value is equals to given mass value 492.2179578
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
3-[2-[[2-[[2-Acetamido-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]propanoylamino]-4-oxobutanoic acid
C23H32N4O8 (492.22200319999996)
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015853 - Cysteine Proteinase Inhibitors Ac-YVAD-CHO (L-709049) is a potent, reversible, specific tetrapeptide interleukin-lβ converting enzyme (ICE) inhibitor with mouse and human Ki values of 3.0 and 0.76 nM. Ac-YVAD-CHO is also a caspase-1 inhibitor. Ac-YVAD-CHO can suppress the production of mature IL-lβ[1][2][3].
2-[4-[2-[(2,4-Difluorophenyl)carbamoyl-heptylamino]ethyl]phenyl]sulfanyl-2-methylpropanoic acid
C26H34F2N2O3S (492.2258078000001)
Ile-Glu-Thr-Asp-fluoromethyl ketone
C20H33FN4O9 (492.22314600000004)
Loperamide oxide
A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07D - Antipropulsives > A07DA - Antipropulsives C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals
L-Alaninamide, N-acetyl-L-tyrosyl-L-valyl-N-((1S)-2-carboxy-1-formylethyl)-
C23H32N4O8 (492.22200319999996)
Tepotinib
Mortonol A
6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl (2E)-3,7-dimethylocta-2,6-dienoate|jasminoside P
8-Ethyl-3-(3-formamidosalicylamido)-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl isovalerate
C24H32N2O9 (492.21077019999996)
GW 9578
C26H34F2N2O3S (492.2258078000001)
Enalapril maleate
C24H32N2O9 (492.21077019999996)
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
2-ethyl-4-[(Z)-2-[(3-formamido-2-hydroxybenzoyl)amino]but-2-enoyl]oxy-3-(2-methylbutanoyloxy)pentanoic acid
C24H32N2O9 (492.21077019999996)
C22H36O12_beta-D-Glucopyranose, 6-O-beta-D-glucopyranosyl-1-O-[(2,6,6-trimethyl-1-cyclohexen-1-yl)carbonyl]
[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl] 2,6,6-trimethylcyclohexene-1-carboxylate
[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl] 2,6,6-trimethylcyclohexene-1-carboxylate_major
Ala Glu His His
Ala His Glu His
Ala His His Glu
Cys Gly Lys Trp
Cys Gly Trp Lys
Cys Lys Gly Trp
Cys Lys Trp Gly
Cys Asn Arg Thr
C17H32N8O7S (492.21145620000004)
Cys Asn Thr Arg
C17H32N8O7S (492.21145620000004)
Cys Gln Arg Ser
C17H32N8O7S (492.21145620000004)
Cys Gln Ser Arg
C17H32N8O7S (492.21145620000004)
Cys Arg Asn Thr
C17H32N8O7S (492.21145620000004)
Cys Arg Gln Ser
C17H32N8O7S (492.21145620000004)
Cys Arg Ser Gln
C17H32N8O7S (492.21145620000004)
Cys Arg Thr Asn
C17H32N8O7S (492.21145620000004)
Cys Ser Gln Arg
C17H32N8O7S (492.21145620000004)
Cys Ser Arg Gln
C17H32N8O7S (492.21145620000004)
Cys Thr Asn Arg
C17H32N8O7S (492.21145620000004)
Cys Thr Arg Asn
C17H32N8O7S (492.21145620000004)
Cys Trp Gly Lys
Cys Trp Lys Gly
Asp Pro Val Tyr
C23H32N4O8 (492.22200319999996)
Asp Pro Tyr Val
C23H32N4O8 (492.22200319999996)
Asp Val Pro Tyr
C23H32N4O8 (492.22200319999996)
Asp Val Tyr Pro
C23H32N4O8 (492.22200319999996)
Asp Tyr Pro Val
C23H32N4O8 (492.22200319999996)
Asp Tyr Val Pro
C23H32N4O8 (492.22200319999996)
Glu Ala His His
Glu Phe Pro Thr
C23H32N4O8 (492.22200319999996)
Glu Phe Thr Pro
C23H32N4O8 (492.22200319999996)
Glu His Ala His
Glu His His Ala
Glu Ile Met Thr
Glu Ile Thr Met
Glu Leu Met Thr
Glu Leu Thr Met
Glu Met Ile Thr
Glu Met Leu Thr
Glu Met Thr Ile
Glu Met Thr Leu
Glu Pro Phe Thr
C23H32N4O8 (492.22200319999996)
Glu Pro Thr Phe
C23H32N4O8 (492.22200319999996)
Glu Thr Phe Pro
C23H32N4O8 (492.22200319999996)
Glu Thr Ile Met
Glu Thr Leu Met
Glu Thr Met Ile
Glu Thr Met Leu
Glu Thr Pro Phe
C23H32N4O8 (492.22200319999996)
Phe Glu Pro Thr
C23H32N4O8 (492.22200319999996)
Phe Glu Thr Pro
C23H32N4O8 (492.22200319999996)
Phe Pro Glu Thr
C23H32N4O8 (492.22200319999996)
Phe Pro Thr Glu
C23H32N4O8 (492.22200319999996)
Phe Thr Glu Pro
C23H32N4O8 (492.22200319999996)
Phe Thr Pro Glu
C23H32N4O8 (492.22200319999996)
Gly Cys Lys Trp
Gly Cys Trp Lys
Gly Lys Cys Trp
Gly Lys Trp Cys
Gly Trp Cys Lys
Gly Trp Lys Cys
His Ala Glu His
His Ala His Glu
His Glu Ala His
His Glu His Ala
His His Ala Glu
His His Glu Ala
Ile Glu Met Thr
Ile Glu Thr Met
Ile Met Glu Thr
Ile Met Thr Glu
Ile Thr Glu Met
Ile Thr Met Glu
Lys Cys Gly Trp
Lys Cys Trp Gly
Lys Gly Cys Trp
Lys Gly Trp Cys
Lys Trp Cys Gly
Lys Trp Gly Cys
Leu Glu Met Thr
Leu Glu Thr Met
Leu Met Glu Thr
Leu Met Thr Glu
Leu Thr Glu Met
Leu Thr Met Glu
Met Glu Ile Thr
Met Glu Leu Thr
Met Glu Thr Ile
Met Glu Thr Leu
Met Ile Glu Thr
Met Ile Thr Glu
Met Leu Glu Thr
Met Leu Thr Glu
Met Thr Glu Ile
Met Thr Glu Leu
Met Thr Ile Glu
Met Thr Leu Glu
Asn Cys Arg Thr
C17H32N8O7S (492.21145620000004)
Asn Cys Thr Arg
C17H32N8O7S (492.21145620000004)
Asn Arg Cys Thr
C17H32N8O7S (492.21145620000004)
Asn Arg Thr Cys
C17H32N8O7S (492.21145620000004)
Asn Thr Cys Arg
C17H32N8O7S (492.21145620000004)
Asn Thr Arg Cys
C17H32N8O7S (492.21145620000004)
Pro Asp Val Tyr
C23H32N4O8 (492.22200319999996)
Pro Asp Tyr Val
C23H32N4O8 (492.22200319999996)
Pro Glu Phe Thr
C23H32N4O8 (492.22200319999996)
Pro Glu Thr Phe
C23H32N4O8 (492.22200319999996)
Pro Phe Glu Thr
C23H32N4O8 (492.22200319999996)
Pro Phe Thr Glu
C23H32N4O8 (492.22200319999996)
Pro Thr Glu Phe
C23H32N4O8 (492.22200319999996)
Pro Thr Phe Glu
C23H32N4O8 (492.22200319999996)
Pro Val Asp Tyr
C23H32N4O8 (492.22200319999996)
Pro Val Tyr Asp
C23H32N4O8 (492.22200319999996)
Pro Tyr Asp Val
C23H32N4O8 (492.22200319999996)
Pro Tyr Val Asp
C23H32N4O8 (492.22200319999996)
Gln Cys Arg Ser
C17H32N8O7S (492.21145620000004)
Gln Cys Ser Arg
C17H32N8O7S (492.21145620000004)
Gln Arg Cys Ser
C17H32N8O7S (492.21145620000004)
Gln Arg Ser Cys
C17H32N8O7S (492.21145620000004)
Gln Ser Cys Arg
C17H32N8O7S (492.21145620000004)
Gln Ser Arg Cys
C17H32N8O7S (492.21145620000004)
Arg Cys Asn Thr
C17H32N8O7S (492.21145620000004)
Arg Cys Gln Ser
C17H32N8O7S (492.21145620000004)
Arg Cys Ser Gln
C17H32N8O7S (492.21145620000004)
Arg Cys Thr Asn
C17H32N8O7S (492.21145620000004)
Arg Asn Cys Thr
C17H32N8O7S (492.21145620000004)
Arg Asn Thr Cys
C17H32N8O7S (492.21145620000004)
Arg Gln Cys Ser
C17H32N8O7S (492.21145620000004)
Arg Gln Ser Cys
C17H32N8O7S (492.21145620000004)
Arg Ser Cys Gln
C17H32N8O7S (492.21145620000004)
Arg Ser Gln Cys
C17H32N8O7S (492.21145620000004)
Arg Thr Cys Asn
C17H32N8O7S (492.21145620000004)
Arg Thr Asn Cys
C17H32N8O7S (492.21145620000004)
Ser Cys Gln Arg
C17H32N8O7S (492.21145620000004)
Ser Cys Arg Gln
C17H32N8O7S (492.21145620000004)
Ser Gln Cys Arg
C17H32N8O7S (492.21145620000004)
Ser Gln Arg Cys
C17H32N8O7S (492.21145620000004)
Ser Arg Cys Gln
C17H32N8O7S (492.21145620000004)
Ser Arg Gln Cys
C17H32N8O7S (492.21145620000004)
Thr Cys Asn Arg
C17H32N8O7S (492.21145620000004)
Thr Cys Arg Asn
C17H32N8O7S (492.21145620000004)
Thr Glu Phe Pro
C23H32N4O8 (492.22200319999996)
Thr Glu Ile Met
Thr Glu Leu Met
Thr Glu Met Ile
Thr Glu Met Leu
Thr Glu Pro Phe
C23H32N4O8 (492.22200319999996)
Thr Phe Glu Pro
C23H32N4O8 (492.22200319999996)
Thr Phe Pro Glu
C23H32N4O8 (492.22200319999996)
Thr Ile Glu Met
Thr Ile Met Glu
Thr Leu Glu Met
Thr Leu Met Glu
Thr Met Glu Ile
Thr Met Glu Leu
Thr Met Ile Glu
Thr Met Leu Glu
Thr Asn Cys Arg
C17H32N8O7S (492.21145620000004)
Thr Asn Arg Cys
C17H32N8O7S (492.21145620000004)
Thr Pro Glu Phe
C23H32N4O8 (492.22200319999996)
Thr Pro Phe Glu
C23H32N4O8 (492.22200319999996)
Thr Arg Cys Asn
C17H32N8O7S (492.21145620000004)
Thr Arg Asn Cys
C17H32N8O7S (492.21145620000004)
Val Asp Pro Tyr
C23H32N4O8 (492.22200319999996)
Val Asp Tyr Pro
C23H32N4O8 (492.22200319999996)
Val Pro Asp Tyr
C23H32N4O8 (492.22200319999996)
Val Pro Tyr Asp
C23H32N4O8 (492.22200319999996)
Val Tyr Asp Pro
C23H32N4O8 (492.22200319999996)
Val Tyr Pro Asp
C23H32N4O8 (492.22200319999996)
Trp Cys Gly Lys
Trp Cys Lys Gly
Trp Gly Cys Lys
Trp Gly Lys Cys
Trp Lys Cys Gly
Trp Lys Gly Cys
Tyr Asp Pro Val
C23H32N4O8 (492.22200319999996)
Tyr Asp Val Pro
C23H32N4O8 (492.22200319999996)
Tyr Pro Asp Val
C23H32N4O8 (492.22200319999996)
Tyr Pro Val Asp
C23H32N4O8 (492.22200319999996)
Tyr Val Asp Pro
C23H32N4O8 (492.22200319999996)
Tyr Val Pro Asp
C23H32N4O8 (492.22200319999996)
N-Ac-Tyr-Val-Ala-Asp-CHO
C23H32N4O8 (492.22200319999996)
Ac-YVAD-CHO (L-709049) is a potent, reversible, specific tetrapeptide interleukin-lβ converting enzyme (ICE) inhibitor with mouse and human Ki values of 3.0 and 0.76 nM. Ac-YVAD-CHO is also a caspase-1 inhibitor. Ac-YVAD-CHO can suppress the production of mature IL-lβ[1][2][3].
6-O-?-D-Glucopyranosyl-1-O-[(2,6,6-trimethyl-1-cyclohexen-1-yl)carbonyl]-?-D-glucopyranose
[6-(2,6-dimethylnaphthalene-1-carbonyl)naphthalen-2-yl]-(2,6-dimethylnaphthalen-1-yl)methanone
tepotinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164000 - c-Met-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D000970 - Antineoplastic Agents
(S)-1-((S)-2-(((R)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanoyl)pyrrolidine-2-carboxylic acid compound with maleic acid (1:1)
C24H32N2O9 (492.21077019999996)
2,2-[1,4-Phenylenebis(methyleneimino-4,1-phenyleneoxy)]bis[2-methylpropanoic acid]
4-Oxo-2-phenylmethanesulfonyl-octahydro-pyrrolo[1,2-A]pyrazine-6-carboxylic acid [1-(N-hydroxycarbamimidoyl)-piperidin-4-ylmethyl]-amide
loperamide
A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07D - Antipropulsives > A07DA - Antipropulsives C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals
H-DL-xiIle-DL-Glu-DL-xiThr-DL-Asp-CH2F
C20H33FN4O9 (492.22314600000004)
3-[[1-[[2-[[2-Acetamido-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]-1-oxopropan-2-yl]amino]-4-oxobutanoic acid
C23H32N4O8 (492.22200319999996)
3-[[4-[[4-(2-methoxyphenyl)-1-piperazinyl]-oxomethyl]cyclohexyl]methyl]-2-sulfanylidene-1H-quinazolin-4-one
C27H32N4O3S (492.21950019999997)
N-[(E)-[3-[[4-(4-fluorophenyl)piperazin-1-yl]methyl]-4-methoxyphenyl]methylideneamino]-4-hydroxy-3-methoxybenzamide
(1S,9R,10R,11R)-10-(hydroxymethyl)-6-oxo-N-(4-phenylphenyl)-12-(pyridin-4-ylmethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-[[3-(trifluoromethyl)phenyl]methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(phenylmethyl)acetamide
(1R,9S,10S,11S)-10-(hydroxymethyl)-6-oxo-N-(4-phenylphenyl)-12-(pyridin-4-ylmethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
2-Ethyl-4-[(z)-2-[(3-formamido-2-hydroxybenzoyl)amino]but-2-enoyl]oxy-3-(2-methylbutanoyloxy)pentanoic acid
C24H32N2O9 (492.21077019999996)